Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-17

Clinical Trial Update: Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AD04 in adults with Alcohol Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AD04

Snippet

Sponsor: Adial Pharmaceuticals | Conditions: Alcohol Use Disorder | Phase 3 | Status: COMPLETED